Biocarbazine R
Biocarbazine R

Biocarbazine R review

Biocarbazine R is a medication used for the treatment of cancer. An alkylating agent, Biocarbazine R is administered either through intravenous infusion or injection.

Biocarbazine R is marketed under the brand names DTIC-Dome, DIC, DTIC, and Imidazole Carboxamide. It is inspireed for patients with metastatic malignant melanoma, fibrosarcomas, soft tissue sarcomas, rhabdomyosarcoma, neuroblastoma, islet cell carcinoma, and carcinoma of the thyroid.


Biocarbazine R can be administered intravenously through cannula usually at the back of a hand, or through a thin plastic tube placed beneath the skin and into a vein close to the collarbone. It can also be administered through a thin tube placed into a vein of the PICC line, or by infusion via the cannula. Such infusion normally takes any where from 30 minutes to 2 hours.

The length of Chemotherapy and the number of treatment cycles depends on the type of cancer being treated. It is also normal for Biocarbazine R to be taken along with other chemotherapy medicaments.

The amount of Biocarbazine R administered depends on numerous factors including the overall health of the patient and the type of condition being treated.


Patients should be informed that their reaction to Biocarbazine R might differ from those of other patients. Some patients experience minimal side effects, while some experience more.

Users of Biocarbazine R may feel sick while using the medication. Nausea and vomiting may become apparent a couple of hours after administration of the medicine. It can last for several days. Doctors usually prescribe anti-emetic medicaments to reduce these symptoms.

Biocarbazine R can also lessen the bone marrow's production of white blood cells. This would result in a patient becoming more susceptible to infections. This side effect can become apparent a week after administration of Biocarbazine R. After a few weeks, the number of white blood cells will steadily increase.

Biocarbazine R can also lessen the number of platelets in the body, which leads to unexplained bleeding or bruising. Patients may suffer from blood spots, nosebleeds, and bleeding gums as a result.

Users of Biocarbazine R may also experience a decreased production of red blood cells or anemia. This usually makes patients feel exhausted and breathless.

Biocarbazine R may also lead to patients losing their appetite and experiencing abnormal baldness. Other unlikely side effects include diarrhoea, sensitivity to sunlight, pain at the injected area, sore ulcers, and flu-like symptoms.

Patients should immediately inform their doctor if these side effects persist or worsen.


Before taking Biocarbazine R, patients should inform their doctor of medicaments that they are taking, whether prescription, non-prescription or herbal medicaments. Patients should also not use medicaments containing aspirin unless given approval by doctors.

It is also not safe for patients to take any sort of immunization while taking Biocarbazine R.


Biocarbazine R may also affect the fertility of the patient. Patients should discuss this with their doctor before beginning to take the medication. It is also not advisable for patients to breast feed while using Biocarbazine R since it may be passed on to the infant.

Biocarbazine r has the following structural formula:

Chemical structure of biocarbazine r

 Molecular formula of biocarbazine r is C6H10N6O
 Chemical IUPAC Name is 5-dimethylaminoazo-3H-imidazole-4-carboxamide
 Molecular weight is 182.183 g/mol
 Biocarbazine r available : 100mg tablets and 200mg tablets

Generic name: Dacarbazine

Brand name(s): Dacarbazino, Dacarbazinum, Deticene, Imidazole Carboxamide

  Your Biocarbazine R review